Life Science Innovator Sigma-Aldrich Raises $22 Million in Funding for Advancing Global Health Solutions

Sigma-Aldrich Corporation is thrilled to announce that it has successfully raised $22 million in a bid to further its mission of solving complex challenges within the life sciences sector. With an unwavering commitment to collaborate with the global scientific community, the company aims to enhance access to healthcare solutions that positively impact lives everywhere. As a provider of unparalleled lab materials, technologies, and services, Sigma-Aldrich has established itself as a leader in the industry—especially since the strategic merger with EMD Millipore in 2015, which consolidated its portfolio to an impressive breadth of 300,000 products, cultivating innovation and driving research forward. The funds raised will be earmarked for advancing research initiatives and developing cutting-edge technologies that simplify, accelerate, and enhance the efficiency and safety of biotech production. This initiative is part of Sigma-Aldrich's broader vision to empower scientists and engineers with the best-in-class resources to tackle the most pressing health challenges of our time. As a key player in the life science business of Merck KGaA, Darmstadt, Germany, and operating as MilliporeSigma in the U.S. and Canada, Sigma-Aldrich is backed by a global workforce of 40,000 employees dedicated to delivering transformative solutions. This latest funding round marks a significant step forward in Sigma-Aldrich's journey to continuously innovate and champion excellence in the life sciences, ultimately benefiting researchers and healthcare professionals working tirelessly to improve patient outcomes globally.